Acknowledgement
본 연구는 한국화학물질관리협회 화학물질 안전관리 전문인력 양성 사업의 지원을 받아 수행되었음.
References
- Ministry of food and drug safety. Good laboratory practice commentary. Chungcheongbuk-do, (2017).
- J. A. Hwang, D. H. Kim, C. C. Shin, E. J. Lee, N. S. Choi, J. S. Gam, "A Study on Establishment of Good Laboratory Practice Guidebook", Regulatory Research on Food, Drug and Cosmetic. Vol.15, No.1 pp. 9-18, (2020).
- H. Kim, A. R. Scialli, "Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease", Toxicological Sciences, Vol.122, No.1 pp. 1-6, (2011). https://doi.org/10.1093/toxsci/kfr088
- J. Y. Han, J. G. Cho, J. M. Oh, "Necessity of Research for Safe Drug use in Pregnant Women", Journal of the Korean Society of Maternal and Child Health. Vol.21, No.3 pp. 159-165, (2017). https://doi.org/10.21896/jksmch.2017.21.3.159
- N. Vargesson, "Thalidomide-induced teratogenesis: History and mechanisms", Birth Defects Research Part C: Embryo Today: Reviews. Vol.105, No.2 pp.140-156, (2015). https://doi.org/10.1002/bdrc.21096
- Good Laboratory Practice (GLP), "https://www.oecd.org/chemicalsafety/testing/good-laboratory-practiceglp.htm", Organisation for economic co-operation and development, (2024).
- Ministry of food and drug safety. KGLP commentary. Chungcheongbuk-do, (2014).
- Ministry of food and drug safety, "Guide to preparing submission materials for recognition of functional health food ingredients", Chungcheongbuk-do, (2022).
- E. Lee, K. Song, I. Yu, "Characterization of test substance in the GLP", Journal of toxicology and public health, Vol.23, No.2 pp. 173-177, (2007). https://doi.org/10.5487/TR.2007.23.2.173
- K. H. Cho, J. S. Kim, M. S. Jeon, K. H. Lee, M. K. Chung, C. W. Song. "Basic Principles of the Validation for Good Laboratory Practice Institutes", Toxicological Research, Vol.25, No.1 pp. 1-8, (2009). https://doi.org/10.5487/TR.2009.25.1.001
- U.S. Food&Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry. (2015).
- EUROPEAN MEDICINES ANGECY. ICH guideline Q2(R2) on validation of analytical procedures. (2022).
- M. L. Whitmire, P. Bryan, T. R. Henry, J. Holbrook, P. Lehmann, T. Mollitor, S. Ohorodnik, D. Reed, H. D. Wietgrefe, "NonClinical dose formulation analysis method validation and sample analysis", The AAPS Journal. Vol.12, No.4 pp. 628-623, (2010).
- M. Whitmire, R. Ross, J. Mwalimu1, L. Porter, M. Whitse, "A Global GLP Approach to Formulation Analysis Method Validation and Sample Analysis", Pharmaceutica Analytica Acta. No.S2 pp. 1-7, (2011).
- U.S. Food&Drug Administration. Good Laboratory Practice for Nonclinical Laboratory Studies. (2010).
- D. W. Huntsinger, "OECD and USA GLP applications", Ann Ist Super Sanita, Vol.44, No.4 pp. 403-406, (2008).